secwatch.observer — SEC 8-K summary
======================================

Issuer:     Genvor Inc (GNVR)
CIK:        0001792941
Form:       8-K
Filed at:   2024-01-23T23:59:59+00:00
Accession:  0001493152-24-003418
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genvor appoints Chad Pawlak CEO, reshuffles executive team; Miller becomes CBO and Interim CFO
--------------------------------------------------------------------------------

- Chad Pawlak appointed CEO with base salary of $300,000/year and up to 30% annual bonus tied to milestones.
- Judith Miller resigns as Interim CEO, becomes CBO and Interim CFO with base salary of $180,000/year plus monthly stock grants.
- Dr. Jesse Jaynes named Chief Scientific Officer; Dr. Clayton Yates resigns as CSO and becomes scientific advisor.
- Executives receive milestone-based equity: Pawlak eligible for up to 4 million shares upon achieving product and regulatory goals.
- Indemnification agreements entered into with all officers and directors effective January 17, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-003418

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer